# Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

> **NCT01020708** · PHASE1 · COMPLETED · sponsor: **Altheus Therapeutics, Inc.** · enrollment: 9 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** mesalamine
- **DRUG:** ALTH12-1:4
- **DRUG:** ALTH12-2:4

## Key facts

- **NCT ID:** NCT01020708
- **Lead sponsor:** Altheus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2011-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020708, "Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01020708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*